US Soy Grower Leaders Attend China’s Top-Level Agricultural Summit

Posted on: December 12, 2016 by in Blog
No Comments

Mr. Wilkins warned Chinese policy advisors that biotech approval delays would not only hurt growers and seed developers, but the environment Continue Reading ...

The Teachers Advisors LLC invests in Biogen Inc. (BIIB) Shares

Posted on: December 11, 2016 by in Blog
No Comments

The fund owned 395,208 shares of the biotechnology company's stock after buying an additional 75,214 shares during the period. Teachers Continue Reading ...

The Rhumbline Advisers Raises its position in Biogen Inc. (BIIB) as a favorable investment target.

Posted on: December 11, 2016 by in Blog
No Comments

The fund owned 357,364 shares of the biotechnology company's stock after buying an additional 8,533 shares during the period. Rhumbline Continue Reading ...

Impact Score Of Puma Biotechnology Inc (NYSE:PBYI) At 81

Posted on: December 11, 2016 by in Blog
No Comments

Puma Biotechnology Inc (NYSE:PBYI) shares have been stated a daily sentiment score of 0.56 for web articles published on 2016-12-09. This Continue Reading ...

Technical Buzz on Generex Biotechnology Corporation (OTCPK:GNBT)

Posted on: December 11, 2016 by in Blog
No Comments

In looking at the Value Composite score for Generex Biotechnology Corporation (OTCPK:GNBT), we see that the firm has a rank of 97. This is Continue Reading ...

Average Directional Index Review for Bioshares Biotechnology Product (BBP)

Posted on: December 11, 2016 by in Blog
No Comments

Currently, the 14-day ADX for Bioshares Biotechnology Product (BBP) is 21.29. Generally speaking, an ADX value from 0-25 would indicate an Continue Reading ...

The 170 Shares of Biogen Inc. (BIIB) are sold by the Duff & Phelps Investment Management Co.

Posted on: December 11, 2016 by in Blog
No Comments

The fund owned 2,910 shares of the biotechnology company's stock after selling 170 shares during the period. Duff & Phelps Investment Continue Reading ...

The Galena Biopharma Inc. (GALE) Receives Buy Rating from Maxim Group

Posted on: December 11, 2016 by in Blog
No Comments

The brokerage currently has a $1.00 price objective on the biotechnology company's stock. Several other brokerages also recently commented Continue Reading ...

ImmunoGen Inc. (IMGN) Receives $6.43 Average PT from Brokerages

Posted on: December 11, 2016 by in Blog
No Comments

Fisher Asset Management LLC now owns 253,701 shares of the biotechnology company's stock valued at $751,000 after buying an additional Continue Reading ...

Cowen and Company Reaffirms Buy Rating for Heron Therapeutics Inc. (HRTX)

Posted on: December 11, 2016 by in Blog
No Comments

Cowen and Company currently has a $40.00 price objective on the biotechnology company's stock. A number of other equities analysts also Continue Reading ...